Our strategy in seven 'Becauses'
Everything we do in the next five years will be based on a single aim – to stop people dying of blood cancer or its treatment.
Because too many people are dying of blood cancer
Everything we do in the next five years will be based on a single aim – to save lives and bring forward the day when no one dies either of blood cancer or the side effects of its treatments.
Because we'll only be able to reach this day by developing better and less toxic treatments
We will treble our research funding over the next five years, from £5 million in 2021/22 to £15 million per year by 2027/28. We’ll also encourage other funders to increase their investment in blood cancer research.
Because some groups of people are less likely to survive than others
We’ll campaign for better healthcare that leads to more people surviving. We’ll start by producing a blood cancer plan for the UK, setting out a roadmap for how we can improve survival rates, looking at things like access to clinical trials and improving diagnosis.
Because right now too many blood cancer deaths are avoidable deaths
We will focus on providing information and support based on the greatest need, and significantly increase the number of people benefiting from our information and services.
Because even people with blood cancer don't always know they have a cancer
Low public awareness and complicated disease names means many people don't realise that their lymphoma or myeloma diagnosis is actually a blood cancer diagnosis. This means many of them are missing out on being part of a supportive community and accessing support. We will focus on building our community and increasing public awareness and understanding of blood cancer.
Because doing all this costs money
We will harness the passion of those who care about beating blood cancer to significantly increase our income, from £14 million in 2021/22 to £27 million in 2027/28.
Because to achieve all this, we'll need to change how we work
We will do five key things to make sure we can deliver our strategy:
- Harness the energy and knowledge of a bigger and more diverse group of people to guide our work.
- Do more work in partnership with others, building strong working relationships with other organisations that share our values and our determination to beat blood cancer.
- Improve how we communicate, so we get better at letting people know what they need to hear, when they need to hear it.
- Improve how we work, making better use of data and technology, and working more iteratively, testing as we go.
- Maintain and build on our high-performing and positive existing culture, so that we remain one of the best places to work in the country.
Next, find out exactly how our new strategy is going to change the landscape for people with blood cancer, from managing infection risk and getting more people onto clinical trials, to funding the next big breakthroughs in blood cancer research.
Next... find out how our new strategy is going to change the landscape for people with blood cancer.
Because we want to change the world for people affected by blood cancer